BRAF and ameloblastoma: The mutational landscape of odontogenic tumors has not been fully characterized, while some proteins involved in the mitogen-activated protein kinase (MAPK) pathway, such as BRAF, play a pivotal role in the development and progress of ameloblastoma (17).